Nabila Abd El Maksoud
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Nabila Abd El Maksoud has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Halla Mohamed Ragab
Biochemistry Department, Genetic Engineering and Biotechnology Research Division, National Research Center, Dokki, Giza Egypt
8 shared publications - Mohab H. Halim
Biochemistry Department, National Research Center, Dokki, Giza, Egypt
3 shared publications Hany Khatab
2 shared publicationsHebatAllah Mohamed Shaaban
Pathology Department, National Cancer Institute, Cairo University, Cairo Egypt
2 shared publicationsHosni Khiry
2 shared publications- Mie Afify
Biochemistry Dept. NRC
2 shared publications
Latest Publications
- Open Access
- 2 May 2022
- Published by Respub Journals
- Vol. 2 (1) , 15-23
Clinical Significance of Serum CD14 and Its Polymorphism as a Biomarker of Non-Alcoholic Fatty Liver Disease
Background: Liver inflammation is deliberated a risk factor for the ongoing liver damage including non-alcoholic steatohepatitis, cirrhosis, and hepatoma. CD14, an effectual mediator for the monocytes activation, has been postulated as a marker of liver inflammation and fibrosis. This study is constructed to detect the alterations in the CD14 serum levels in 40 NAFLD cases and 14 healthy controls along with to analyze the role of CD14 polymorphisms in the causation and severity of Non-Alcoholic Fatty Liver Disease (NAFLD). Liver enzymes, glycated hemoglobin, together with lipid profile were estimated in all included subjects. The diagnosis of NAFLD depends largely on ultrasonography. NAFLD fibrosis score and FIB-4 score were calculated. Serum CD14 was quantified by EnzymeLinked Immunosorbent Assay (ELISA) and C14-159C/T SNP was genotyped via Polymerase Chain Reaction (PCR) and Restriction Fragment Length Polymorphisms (RFLP). Results: Serum CD14 was markedly higher in the diabetic subjects either lean or overweight/obese than the controls (P0.676 (P=1.000). Conclusion: The former observations advocate the potential role of CD14 in both the pathogenesis and progression of NAFLD. Yet, it didn't correlate with the NFS, consequently it couldn't forecast the severity of the disease. Furthermore, no association was distinguished linking CD14 C-(159) T polymorphism and the risk of NAFLD occurrence.
- 2 May 2022
- Published by Respub Journals
- Vol. 2 (1) , 15-23
Open AccessClinical Significance of Serum CD14 and Its Polymorphism as a Biomarker of Non-Alcoholic Fatty Liver Disease
Background: Liver inflammation is deliberated a risk factor for the ongoing liver damage including non-alcoholic steatohepatitis, cirrhosis, and hepatoma. CD14, an effectual mediator for the monocytes activation, has been postulated as a marker of liver inflammation and fibrosis. This study is constructed to detect the alterations in the CD14 serum levels in 40 NAFLD cases and 14 healthy controls along with to analyze the role of CD14 polymorphisms in the causation and severity of Non-Alcoholic Fatty Liver Disease (NAFLD). Liver enzymes, glycated hemoglobin, together with lipid profile were estimated in all included subjects. The diagnosis of NAFLD depends largely on ultrasonography. NAFLD fibrosis score and FIB-4 score were calculated. Serum CD14 was quantified by EnzymeLinked Immunosorbent Assay (ELISA) and C14-159C/T SNP was genotyped via Polymerase Chain Reaction (PCR) and Restriction Fragment Length Polymorphisms (RFLP). Results: Serum CD14 was markedly higher in the diabetic subjects either lean or overweight/obese than the controls (P0.676 (P=1.000). Conclusion: The former observations advocate the potential role of CD14 in both the pathogenesis and progression of NAFLD. Yet, it didn't correlate with the NFS, consequently it couldn't forecast the severity of the disease. Furthermore, no association was distinguished linking CD14 C-(159) T polymorphism and the risk of NAFLD occurrence.
- Open Access
- 1 January 2020
- Published by FapUNIFESP (SciELO) in Anais da Academia Brasileira de Ciências
- Vol. 92 (4) , e20200574
Epigallocatechin gallate-capped gold nanoparticles enhanced the tumor suppressors let-7a and miR-34a in hepatocellular carcinoma cells
Epigallocatechin gallate (EGCG), major constituent of green tea, possesses antioxidant, antiviral, and anticancer activities. Gold nanoparticles (AuNPs) play an important role in drug delivery due to their stability, ease of surface functionalization, and unique optical properties. This study aimed to investigate the influence of EGCG-capped AuNPs on tumor suppressor miRNAs (miR-34a and let-7a) and their targeted cell death mediators in HepG2 cells, compared with celastrol. EGCG-AuNPs were prepared and characterized. antioxidant activity was estimated by DPPH scavenging assay; cytotoxicity was assessed by MTT assay; let-7a and miR-34a expression was analyzed by qPCR; and miRNAs targets (c-Myc and caspase-3) were assessed by ELISA and immunocytofluorescence, respectively. The average size of EGCG-AuNPs was 35 nm, with a λmax of ~535 nm. EGCG-AuNPs exerted cytotoxicity on HepG2 cells stronger than that of EGCG alone. EGCG-AuNPs and EGCG presented half-maximal radical scavenging concentrations (SC50) of 539 µg/ml and 45 µg/ml, respectively. The expression levels of let-7a and miR-34a were significantly elevated in HepG2 cells after EGCG-AuNP treatment for 72 h. c-Myc protein expression was reduced, whereas caspase-3 expression was increased following treatment with EGCG-AuNPs. In conclusion, Au-NPs are effective carrier for EGCG, and EGCG-AuNPs are promising anti-cancer agent.
- 1 January 2020
- Published by FapUNIFESP (SciELO) in Anais da Academia Brasileira de Ciências
- Vol. 92 (4) , e20200574
Open AccessEpigallocatechin gallate-capped gold nanoparticles enhanced the tumor suppressors let-7a and miR-34a in hepatocellular carcinoma cells
Epigallocatechin gallate (EGCG), major constituent of green tea, possesses antioxidant, antiviral, and anticancer activities. Gold nanoparticles (AuNPs) play an important role in drug delivery due to their stability, ease of surface functionalization, and unique optical properties. This study aimed to investigate the influence of EGCG-capped AuNPs on tumor suppressor miRNAs (miR-34a and let-7a) and their targeted cell death mediators in HepG2 cells, compared with celastrol. EGCG-AuNPs were prepared and characterized. antioxidant activity was estimated by DPPH scavenging assay; cytotoxicity was assessed by MTT assay; let-7a and miR-34a expression was analyzed by qPCR; and miRNAs targets (c-Myc and caspase-3) were assessed by ELISA and immunocytofluorescence, respectively. The average size of EGCG-AuNPs was 35 nm, with a λmax of ~535 nm. EGCG-AuNPs exerted cytotoxicity on HepG2 cells stronger than that of EGCG alone. EGCG-AuNPs and EGCG presented half-maximal radical scavenging concentrations (SC50) of 539 µg/ml and 45 µg/ml, respectively. The expression levels of let-7a and miR-34a were significantly elevated in HepG2 cells after EGCG-AuNP treatment for 72 h. c-Myc protein expression was reduced, whereas caspase-3 expression was increased following treatment with EGCG-AuNPs. In conclusion, Au-NPs are effective carrier for EGCG, and EGCG-AuNPs are promising anti-cancer agent.
- Open Access
- 1 December 2017
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 15 (2) , 403-407
Significance of growth differentiation factor 15 in chronic HCV patients
- 1 December 2017
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 15 (2) , 403-407
Open AccessSignificance of growth differentiation factor 15 in chronic HCV patients
- Open Access
- 1 January 2017
- Published by Open Science Publishers LLP in Journal of Applied Pharmaceutical Science
- Vol. 7 (3) , 057-061
Evaluation of serum soluble E-selectin in breast cancer
Breast cancer is a highly metastatic disease even after surgical removal of the primary tumor. Metastasis is the main cause of death in breast cancer patients. The aim of the study was to assess the concentration of E-selectin in serum and tissue from breast cancer patients and women suffering from benign breast disease to determine its prognostic value in these diseases. This study was conducted on three groups of patients: Group A included 92 breast cancer patients, Group B included 25 patients with benign breast and group C (the control group) included 16 subjects. Blood samples were withdrawn for the estimation of serum E-selectin by ELISA and the gene expression of E-selectin was examined in Breast tissue samples. The results showed that serum level of E-selectin was highly significantly increased in malignant group as compared to benign and control groups (P < 0.05), it increased with the progression of disease. E-selectin serum level showed non-significant difference between benign and control groups. E-selectin gene was expressed in 76.1% in malignant tissues, in 44.0 % in benign tissues and in only one case in control group (6.2%). These results show highly significant difference between the diseased groups and the controls. The expression of E-selectin significantly correlated with aggressive tumor behavior. In conclusion, we found that the assessment of the adhesion molecule E-selectin in women with breast cancer can be added to the panel of tests that monitor the progress of the disease.
- 1 January 2017
- Published by Open Science Publishers LLP in Journal of Applied Pharmaceutical Science
- Vol. 7 (3) , 057-061
Open AccessEvaluation of serum soluble E-selectin in breast cancer
Breast cancer is a highly metastatic disease even after surgical removal of the primary tumor. Metastasis is the main cause of death in breast cancer patients. The aim of the study was to assess the concentration of E-selectin in serum and tissue from breast cancer patients and women suffering from benign breast disease to determine its prognostic value in these diseases. This study was conducted on three groups of patients: Group A included 92 breast cancer patients, Group B included 25 patients with benign breast and group C (the control group) included 16 subjects. Blood samples were withdrawn for the estimation of serum E-selectin by ELISA and the gene expression of E-selectin was examined in Breast tissue samples. The results showed that serum level of E-selectin was highly significantly increased in malignant group as compared to benign and control groups (P < 0.05), it increased with the progression of disease. E-selectin serum level showed non-significant difference between benign and control groups. E-selectin gene was expressed in 76.1% in malignant tissues, in 44.0 % in benign tissues and in only one case in control group (6.2%). These results show highly significant difference between the diseased groups and the controls. The expression of E-selectin significantly correlated with aggressive tumor behavior. In conclusion, we found that the assessment of the adhesion molecule E-selectin in women with breast cancer can be added to the panel of tests that monitor the progress of the disease.
- 15 June 2016
- Published by Science Alert in International Journal of Cancer Research
- Vol. 12 (3-4) , 152-161
Expression of Vascular Endothelial Growth Factor Protein in Both Serum Samples and Excised Tumor Tissues of Breast Carcinoma Patients
- 15 June 2016
- Published by Science Alert in International Journal of Cancer Research
- Vol. 12 (3-4) , 152-161
Expression of Vascular Endothelial Growth Factor Protein in Both Serum Samples and Excised Tumor Tissues of Breast Carcinoma Patients
- Open Access
- 15 December 2013
- Published by Scientific Foundation Spiroski (publications) in Open Access Macedonian Journal of Medical Sciences
- Vol. 1 (1) , 21-26
Validity of Autotaxin as a Novel Diagnostic Marker for Liver Fibrosis in Egyptian Chronic HCV Patients
We aimed to detect the validity of serum ATX as a diagnostic marker for liver fibrosis. Forty-eight males and 16 females were enrolled in the current study. Their ages ranged from 29-57 years with mean of 45.09, all were chronically HCV infected. Laboratory assessment was done for all subjects in form of complete blood picture; liver function test; lipid profile and serum detection of ATX. Patients were grouped according to the stage of fibrosis into group 1: fibrosis score 0, 1, 2, 3; group 2: fibrosis score: 4, 5, 6.The mean values of ATX in all studied patients with chronic HCV infection was 63.02 ± 36.29 while that of healthy controls was 65.31 ± 12.24 without any significant difference. Surprisingly, mean values of ATX were higher among patients with group 1 but it did not reach the significant level. In each group of them, the differences between mean values of ATX among different grades of liver fibrosis were insignificant. It was also noticed that the mean values of ATX were higher among men than in women .It was concluded that Autotoxin might not be used as a useful diagnostic marker for liver fibrosis in Egyptian chronic HCV patients.
- 15 December 2013
- Published by Scientific Foundation Spiroski (publications) in Open Access Macedonian Journal of Medical Sciences
- Vol. 1 (1) , 21-26
Open AccessValidity of Autotaxin as a Novel Diagnostic Marker for Liver Fibrosis in Egyptian Chronic HCV Patients
We aimed to detect the validity of serum ATX as a diagnostic marker for liver fibrosis. Forty-eight males and 16 females were enrolled in the current study. Their ages ranged from 29-57 years with mean of 45.09, all were chronically HCV infected. Laboratory assessment was done for all subjects in form of complete blood picture; liver function test; lipid profile and serum detection of ATX. Patients were grouped according to the stage of fibrosis into group 1: fibrosis score 0, 1, 2, 3; group 2: fibrosis score: 4, 5, 6.The mean values of ATX in all studied patients with chronic HCV infection was 63.02 ± 36.29 while that of healthy controls was 65.31 ± 12.24 without any significant difference. Surprisingly, mean values of ATX were higher among patients with group 1 but it did not reach the significant level. In each group of them, the differences between mean values of ATX among different grades of liver fibrosis were insignificant. It was also noticed that the mean values of ATX were higher among men than in women .It was concluded that Autotoxin might not be used as a useful diagnostic marker for liver fibrosis in Egyptian chronic HCV patients.
- Open Access
- 1 June 2012
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 10 (1) , 81-86
Serum levels of trace elements in Egyptian patients with chronic hepatitis C under interferon therapy
- 1 June 2012
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 10 (1) , 81-86
Open AccessSerum levels of trace elements in Egyptian patients with chronic hepatitis C under interferon therapy
- 1 May 2012
- Published by Medknow in Journal of the Egyptian Womenʼs Dermatologic Society
- Vol. 9 (2) , 86-91
Psoriasis vulgaris severity and body mass index
- 1 May 2012
- Published by Medknow in Journal of the Egyptian Womenʼs Dermatologic Society
- Vol. 9 (2) , 86-91
Psoriasis vulgaris severity and body mass index
- Open Access
- 1 December 2011
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 9 (2) , 133-136
Predictive value of cystatin C and beta-2 microglobulin in preeclampsia
- 1 December 2011
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 9 (2) , 133-136
Open AccessPredictive value of cystatin C and beta-2 microglobulin in preeclampsia